| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/11/2008 | CN101195656A Recombined Japanese lamprey glandulae oris excreted L-250 protein anticoagulant efficacy |
| 06/11/2008 | CN101194996A Chinese medicine ejection preparation and method for preparing the same |
| 06/11/2008 | CN101194924A Use of lespedeza virgata in preparing medicament for activating blood circulation and removing stasis |
| 06/11/2008 | CN101194720A Medicinal food for air make-up and blood-nourishing |
| 06/11/2008 | CN100393747C Novel albumins |
| 06/11/2008 | CN100393323C Methods of treating vascular disease |
| 06/11/2008 | CN100393313C Bilobalide B powder injection and its preparing method |
| 06/10/2008 | US7385042 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384917 oligopeptides having renin suppression, diuretic and/or vasodilator activity in mammals; treating congestive heart failure |
| 06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | CA2329768C Pharmaceutical composition comprising factor viii and neutral liposomes |
| 06/10/2008 | CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents |
| 06/05/2008 | WO2008067126A2 Methods for using aldhbr cells to supplement stem cell transplantation |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066117A1 Cyclic amine compound |
| 06/05/2008 | WO2008066102A1 Sustained release preparation |
| 06/05/2008 | WO2008065503A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [ ( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
| 06/05/2008 | WO2008065445A1 Amino quinazolines derivatives wuth blood platelet reducing properties |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132553 Preventing and reversing the formation of advance glycosylation endproducts |
| 06/05/2008 | US20080132499 Platelet adp receptor inhibitors |
| 06/05/2008 | US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides |
| 06/05/2008 | US20080131565 Edible composition; partially defatted cocoa solids prepared by heating slaty and/or purple cocoa beans, winnowing the cocoa nibs from the cocoa shells; pressing the cocoa nibs to produce cocoa butter, recovering the cocoa butter and solids; adding the recovered, defatted cocoa solids |
| 06/05/2008 | US20080131474 Promoting cardiac tissue repair while inhibiting or reducing vascular occlusion and/or restenosis |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | CA2670976A1 Cyclic amine compound |
| 06/05/2008 | CA2670595A1 (r)-5-methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chlorophenyl)amide 5-{[2-fluoro-4-(2-oxo-2h-pyridin-1-yl)-phenyl)amide) as a fact or xa inhibitor |
| 06/05/2008 | CA2670313A1 Polymorphic forms of deferasirox (icl670a) |
| 06/05/2008 | CA2670168A1 Amino quinazolines derivatives wuth blood platelet reducing properties |
| 06/05/2008 | CA2668608A1 Methods for using aldhbr cells to supplement stem cell transplantation |
| 06/04/2008 | EP1927591A1 Polymorphic Forms of Deferasirox (ICL670) |
| 06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1927363A1 An extract for preventing or treating thrombotic diseases |
| 06/04/2008 | EP1927358A1 Sustained-release preparation |
| 06/04/2008 | EP1926743A1 2-(AMINOMETHYL)-5-CHLOROBENZYLAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE CLOTTING FACTOR Xa |
| 06/04/2008 | EP1663952B1 Abiotic heparin antagonists |
| 06/04/2008 | CN101193656A Novel triglyceride reducing agent |
| 06/04/2008 | CN101193632A Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 06/04/2008 | CN101190945A Preparation for specificity anticoagulant substance and application thereof |
| 06/04/2008 | CN101190943A Jiangzhe snake venom double-chain peptide, preparation method and application thereof |
| 06/04/2008 | CN101190942A Compound with thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190941A Polypeptide with thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190940A Polypeptide with target antithrombotic activity and its preparation method and application |
| 06/04/2008 | CN101190939A Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application |
| 06/04/2008 | CN101190915A Anti-thrombus N-butyl-2,2-dimethyl-4-oxy-tetrahydroimidazopyridoindole and its synthesis and application |
| 06/04/2008 | CN101190895A N-[(3S)-1,2,3,4-tetrahydroisoquinolino-3-formacyl]amino acid, preparation method and application thereof |
| 06/04/2008 | CN101190297A Traditional Chinese medicine compound preparations for preventing and controlling abnormal uterine bleeding after medical abortion |
| 06/04/2008 | CN101190281A Prune tree extract and preparation method and application thereof |
| 06/04/2008 | CN101190263A Rhubarb chewable tablets and preparation method and application thereof |
| 06/04/2008 | CN101190236A Donkey hide gelatin injection plasma substitutes and preparation method thereof |
| 06/04/2008 | CN101190234A Virus deactivation bagged freeze-dried plasma and uses thereof |
| 06/04/2008 | CN101190209A Low molecule heparin sustained-release controlled-release capsule preparations and preparation method thereof |
| 06/04/2008 | CN101190202A Hydrochlorothiazidum chewable tablets for dog or cat |
| 06/04/2008 | CN101190201A Folic acid chewable tablets for dog or cat |
| 06/04/2008 | CN101190192A Furosemide chewable tablets for dog or cat |
| 06/04/2008 | CN101190189A Low molecule heparin mucous membrane adhesive tablet preparations and preparation method thereof |
| 06/04/2008 | CN101190033A Pith compensating food |
| 06/04/2008 | CN100392079C Protein C or activated protein C-like molecules |
| 06/04/2008 | CN100391957C Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide, preparation method thereof and use as medicine preparation |
| 06/04/2008 | CN100391535C Application of enzymic hemostat in antagonizing hirudin hemorrhage |
| 06/04/2008 | CN100391487C Preparation for treating leukopenia and its preparation method |
| 06/04/2008 | CN100391474C Injection medicine for treating platelet abatement |
| 06/04/2008 | CN100391470C Antithrombogenic platiniferous ceramic composition and article containing the same |
| 06/04/2008 | CN100391465C Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 06/04/2008 | CN100391441C Matrine elaioplast drop ball and its preparation method |
| 06/04/2008 | CN100391440C Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base |
| 06/03/2008 | US7381804 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381733 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 06/03/2008 | US7381732 inhibitors of trypsin-like serine proteases; anticoagulant agents to treat thromboembolic disorders; |
| 06/03/2008 | US7381521 Anti-pathogenic composition useful in blood preservation |
| 06/03/2008 | CA2435954C Preparation of non-crystalline atorvastatin calcium |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2186269C Wound healing |
| 06/03/2008 | CA2178144C Stabilized aqueous liquid preparations of blood coagulation factor xiii |
| 05/29/2008 | WO2008063898A2 Methods of treating idiopathic thrombocytopenia purpura using a gm-csf antagonist |
| 05/29/2008 | WO2008063157A2 A nanoparticle-based anticoagulant |
| 05/29/2008 | WO2008062814A1 Hydrogen-dissolved aqueous solution and method for prolonging the life duration of hydrogen dissolved in the aqueous solution |
| 05/29/2008 | WO2008062770A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 05/29/2008 | WO2008061303A1 Method of treatment and prophylaxis |
| 05/29/2008 | WO2008041131A3 Anticoagulant compounds |
| 05/29/2008 | WO2007149283A3 Use of kw-3902 for achieving diuresis in patients with congestive heart failure and acute fluid overload |
| 05/29/2008 | WO2007120766A3 Erythropoietin receptor agonists |
| 05/29/2008 | US20080125488 Lactate Containing Pharmaceutical Composition and Uses Thereof |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125409 N-tert-butyl-5-(5-methanesulfonylamino-2-pyridyl)-1-(6-methoxy-3-pyridyl)-1H-1,2,4-triazole-3-carboxamide; prophylactic and/or therapeutic agent for ischemic diseases; platelet aggregation suppressant |
| 05/29/2008 | US20080125383 For host undergoing surgery or coronary artery bypass |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124390 Antidepressants for treating manic disorders, psychosis; comprising ethyl cellulose, talc, polyvinylpyrrolidone; time-release dosage form; once daily |
| 05/29/2008 | US20080124348 Immune regulation |
| 05/29/2008 | DE102006054757A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 05/28/2008 | EP1925617A1 Heterocyclic compound, and production process and use thereof |
| 05/28/2008 | EP1924291A2 Factor xa inhibitor inclusion complex with cyclodextrin |